CN119386123A - 一种用于治疗过敏性鼻炎的口服组合物 - Google Patents
一种用于治疗过敏性鼻炎的口服组合物 Download PDFInfo
- Publication number
- CN119386123A CN119386123A CN202410970710.0A CN202410970710A CN119386123A CN 119386123 A CN119386123 A CN 119386123A CN 202410970710 A CN202410970710 A CN 202410970710A CN 119386123 A CN119386123 A CN 119386123A
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- allergic rhinitis
- treating
- wind
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010039085 Rhinitis allergic Diseases 0.000 title claims abstract description 52
- 201000010105 allergic rhinitis Diseases 0.000 title claims abstract description 52
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 239000003814 drug Substances 0.000 claims abstract description 60
- 229940079593 drug Drugs 0.000 claims abstract description 25
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 12
- 241000218378 Magnolia Species 0.000 claims abstract description 12
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 10
- 241000132012 Atractylodes Species 0.000 claims abstract description 9
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 9
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 9
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 8
- 239000009636 Huang Qi Substances 0.000 claims abstract description 7
- 240000005528 Arctium lappa Species 0.000 claims abstract description 6
- 235000003130 Arctium lappa Nutrition 0.000 claims abstract description 6
- 235000008078 Arctium minus Nutrition 0.000 claims abstract description 6
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 5
- 240000001949 Taraxacum officinale Species 0.000 claims abstract description 5
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 5
- 235000011477 liquorice Nutrition 0.000 claims abstract description 5
- 241000721047 Danaus plexippus Species 0.000 claims abstract description 4
- 241000050051 Chelone glabra Species 0.000 claims abstract 4
- 241000212322 Levisticum officinale Species 0.000 claims abstract 4
- 239000001645 levisticum officinale Substances 0.000 claims abstract 4
- 244000081426 Ranunculus ficaria Species 0.000 claims abstract 2
- 235000002226 Ranunculus ficaria Nutrition 0.000 claims abstract 2
- 239000002775 capsule Substances 0.000 claims abstract 2
- 238000011282 treatment Methods 0.000 claims description 15
- 235000006533 astragalus Nutrition 0.000 claims description 10
- 241001061264 Astragalus Species 0.000 claims description 7
- 210000004233 talus Anatomy 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 241000112528 Ligusticum striatum Species 0.000 claims description 5
- 244000197580 Poria cocos Species 0.000 claims description 4
- 235000008599 Poria cocos Nutrition 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 241001573366 Astragalus membranaceus Species 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000008188 pellet Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 57
- 210000004072 lung Anatomy 0.000 abstract description 54
- 210000000952 spleen Anatomy 0.000 abstract description 42
- 208000024891 symptom Diseases 0.000 abstract description 32
- 230000007812 deficiency Effects 0.000 abstract description 25
- 238000005728 strengthening Methods 0.000 abstract description 15
- 238000002360 preparation method Methods 0.000 abstract description 9
- 230000001976 improved effect Effects 0.000 abstract description 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 2
- 230000001717 pathogenic effect Effects 0.000 description 31
- 230000001737 promoting effect Effects 0.000 description 24
- 208000002193 Pain Diseases 0.000 description 23
- 239000008280 blood Substances 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 19
- 230000000144 pharmacologic effect Effects 0.000 description 18
- 206010039101 Rhinorrhoea Diseases 0.000 description 17
- 208000010753 nasal discharge Diseases 0.000 description 17
- 206010062717 Increased upper airway secretion Diseases 0.000 description 16
- 206010028748 Nasal obstruction Diseases 0.000 description 16
- 208000026435 phlegm Diseases 0.000 description 16
- 210000001331 nose Anatomy 0.000 description 15
- 238000011160 research Methods 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 14
- 208000004880 Polyuria Diseases 0.000 description 13
- 230000035619 diuresis Effects 0.000 description 13
- 206010039083 rhinitis Diseases 0.000 description 13
- 230000008961 swelling Effects 0.000 description 13
- 241000628997 Flos Species 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 210000002850 nasal mucosa Anatomy 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 230000001939 inductive effect Effects 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- 230000003405 preventing effect Effects 0.000 description 10
- 208000006820 Arthralgia Diseases 0.000 description 9
- 206010019233 Headaches Diseases 0.000 description 9
- 206010061218 Inflammation Diseases 0.000 description 9
- 206010052437 Nasal discomfort Diseases 0.000 description 9
- 206010030113 Oedema Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 230000004054 inflammatory process Effects 0.000 description 9
- 208000011580 syndromic disease Diseases 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 8
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 8
- 231100000869 headache Toxicity 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 8
- 239000002398 materia medica Substances 0.000 description 8
- 210000002435 tendon Anatomy 0.000 description 8
- 231100000331 toxic Toxicity 0.000 description 8
- 230000002588 toxic effect Effects 0.000 description 8
- 201000007100 Pharyngitis Diseases 0.000 description 7
- 208000033809 Suppuration Diseases 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 208000008454 Hyperhidrosis Diseases 0.000 description 6
- 206010068319 Oropharyngeal pain Diseases 0.000 description 6
- 208000005392 Spasm Diseases 0.000 description 6
- 229940107666 astragalus root Drugs 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 238000010926 purge Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 241000245665 Taraxacum Species 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 239000013566 allergen Substances 0.000 description 5
- 230000000172 allergic effect Effects 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 201000009240 nasopharyngitis Diseases 0.000 description 5
- 230000008506 pathogenesis Effects 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 4
- 206010025421 Macule Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 206010042674 Swelling Diseases 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 239000009670 cang er zi wan Substances 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 229960001340 histamine Drugs 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 102000004388 Interleukin-4 Human genes 0.000 description 3
- 108090000978 Interleukin-4 Proteins 0.000 description 3
- 241000229179 Ledebouriella Species 0.000 description 3
- 208000030880 Nose disease Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 240000004534 Scutellaria baicalensis Species 0.000 description 3
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241001506766 Xanthium Species 0.000 description 3
- 206010000269 abscess Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 239000000739 antihistaminic agent Substances 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 206010013023 diphtheria Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 201000003453 lung abscess Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 208000004396 mastitis Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 201000009890 sinusitis Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 210000001944 turbinate Anatomy 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 241001529821 Agastache Species 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 2
- 206010006002 Bone pain Diseases 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 235000017443 Hedysarum boreale Nutrition 0.000 description 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 2
- 102000003834 Histamine H1 Receptors Human genes 0.000 description 2
- 108090000110 Histamine H1 Receptors Proteins 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 102100037850 Interferon gamma Human genes 0.000 description 2
- 108010074328 Interferon-gamma Proteins 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 206010028750 Nasal oedema Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 241000207929 Scutellaria Species 0.000 description 2
- 241000607764 Shigella dysenteriae Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241001251949 Xanthium sibiricum Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 229940125715 antihistaminic agent Drugs 0.000 description 2
- 210000003651 basophil Anatomy 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 201000009151 chronic rhinitis Diseases 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 239000003246 corticosteroid Substances 0.000 description 2
- 229960001334 corticosteroids Drugs 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 210000002443 helper t lymphocyte Anatomy 0.000 description 2
- -1 herba Centipedae Substances 0.000 description 2
- 210000003630 histaminocyte Anatomy 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 230000037315 hyperhidrosis Effects 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000004630 mental health Effects 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000002636 symptomatic treatment Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- DZUXGQBLFALXCR-UHFFFAOYSA-N (+)-(9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprost-13-en-1-oic acid Natural products CCCCCC(O)C=CC1C(O)CC(O)C1CCCCCCC(O)=O DZUXGQBLFALXCR-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- DZUXGQBLFALXCR-BMPPNWMBSA-N 7-[(1R,3R,5S)-3,5-Dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]heptanoic acid Chemical compound CCCCC[C@H](O)\C=C\C1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(O)=O DZUXGQBLFALXCR-BMPPNWMBSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010001076 Acute sinusitis Diseases 0.000 description 1
- 241001412627 Adenophora liliifolia Species 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000489492 Arisaema Species 0.000 description 1
- 241000758794 Asarum Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 1
- 241001233914 Chelidonium majus Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241001481833 Coryphaena hippurus Species 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000218671 Ephedra Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010052140 Eye pruritus Diseases 0.000 description 1
- 206010016059 Facial pain Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- KFFCKOBAHMGTMW-LGQRSHAYSA-N Forsythin Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1[C@@H](CO[C@@H]2C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=CC=3)[C@@H]2CO1 KFFCKOBAHMGTMW-LGQRSHAYSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000000543 Histamine Receptors Human genes 0.000 description 1
- 108010002059 Histamine Receptors Proteins 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- GWNVDXQDILPJIG-SHSCPDMUSA-N Leukotriene C4 Natural products CCCCCC=C/CC=C/C=C/C=C/C(SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C(O)CCCC(=O)O GWNVDXQDILPJIG-SHSCPDMUSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000021642 Muscular disease Diseases 0.000 description 1
- 208000026344 Nasal disease Diseases 0.000 description 1
- 240000002948 Ophiopogon intermedius Species 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 241000951473 Schizonepeta Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 210000000447 Th1 cell Anatomy 0.000 description 1
- 210000004241 Th2 cell Anatomy 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 201000003462 adenoid hypertrophy Diseases 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002590 anti-leukotriene effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 210000000612 antigen-presenting cell Anatomy 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000010231 banlangen Substances 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 229960004342 cetirizine hydrochloride Drugs 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 201000011666 conjunctival pterygium Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002505 effect on nervous system Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229960000289 fluticasone propionate Drugs 0.000 description 1
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000000938 histamine H1 antagonist Substances 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- GWNVDXQDILPJIG-NXOLIXFESA-N leukotriene C4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O GWNVDXQDILPJIG-NXOLIXFESA-N 0.000 description 1
- YEESKJGWJFYOOK-IJHYULJSSA-N leukotriene D4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@H](N)C(=O)NCC(O)=O YEESKJGWJFYOOK-IJHYULJSSA-N 0.000 description 1
- 229940065725 leukotriene receptor antagonists for obstructive airway diseases Drugs 0.000 description 1
- 239000003199 leukotriene receptor blocking agent Substances 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 229960003088 loratadine Drugs 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 229960002744 mometasone furoate Drugs 0.000 description 1
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 description 1
- 229960001951 montelukast sodium Drugs 0.000 description 1
- LBFBRXGCXUHRJY-HKHDRNBDSA-M montelukast sodium Chemical compound [Na+].CC(C)(O)C1=CC=CC=C1CC[C@H](C=1C=C(\C=C\C=2N=C3C=C(Cl)C=CC3=CC=2)C=CC=1)SCC1(CC([O-])=O)CC1 LBFBRXGCXUHRJY-HKHDRNBDSA-M 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000009024 positive feedback mechanism Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000023718 relaxation of cardiac muscle Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000016686 tic disease Diseases 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 229960002117 triamcinolone acetonide Drugs 0.000 description 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000010085 xinqin Substances 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physiology (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种药物组合物,尤其是一种用于治疗过敏性鼻炎的口服组合物,以辛夷、黄芩为君药,白芷、防风、川芎、黄芪、茯苓为臣药,甘草为使,其他为佐药,按质量份计,包括下述组份:2~3份辛夷、2~3份白芷、3~5份连翘、3~5份炒牛蒡子、2~3份防风、3~5份蒲公英、3~5份黄芪、3~5份黄芩、3~5份茯苓、3~5份白术、10~15份薏苡仁、2~3份川芎、2~3份玄参、1~2份甘草。本发明具有疏风清肺、宣通鼻窍、益气健脾的功效的用于风热犯肺兼脾气虚弱型过敏性鼻炎的中药制剂,减轻了患者的症状,提高广大患儿的生活质量。
Description
技术领域
本发明涉及一种药物组合物,尤其是一种用于治疗过敏性鼻炎的口服组合物。
背景技术
过敏性性鼻炎又称为变应性鼻炎,指易感个体与致敏原相接触后,在免疫球蛋白、免疫活性细胞等影响下,主要由特异性IgE介导的、以阵发性喷嚏、清水样涕、鼻塞、鼻痒等症状为主的鼻粘膜I型变态反应性疾病。是影响儿童身心健康、学习成绩和生活质量的主要鼻部疾病,患病率高,具有较大的社会影响。
儿童过敏性鼻炎是临床常见多发病,一年四季均可发病,1至18岁均可发病。全球估计6-7岁儿童过敏性鼻炎发病率为8.5%,13-14岁儿童中为14.6%。虽然病变主要表现在鼻部,但常诱发多种并发症,如:中耳炎、鼻窦炎、哮喘、咽炎、腺样体肥大等,还易共患多动症和抽动障碍等疾病。严重影响儿童身心健康、学习成绩和生活质量。因此持续上升的儿童过敏性鼻炎发病率已不但是医疗问题,更是一个社会问题。
过敏性鼻炎的主要发病机制主要是1型辅助性T 细胞(T helper type 1 cell,Th1)/2型辅助性T 细胞(T helper type 2 cell,Th2)细胞分化失平衡,其产生的细胞因子影响了IgE产生的调节通路,从而导致疾病的发生。在遗传易感性的个体,IL-4启动了正反馈机制使Th2反应过度,致使分化向Th2方向偏移,导致过敏性鼻炎的发生。而IFN-γ是Th1细胞释放可抑制IL-4的mRNA表达及蛋白的合成,抑制Th2细胞的分化。因此,IFN-γ、IL-4的表达水平是调节Th1/Th2平衡的关键因子。一旦表达异常就会导致Th1/Th2失衡,引发以鼻腔粘膜Th2免疫反应为主,由IgE介导的鼻粘膜慢性炎症反应,引起过敏性鼻炎的发生,出现喷嚏、流清水样涕、鼻塞、眼痒等症状。
患儿在机体出现过敏性鼻炎症状前,首先经历了变应原致敏过程,当机体再次与变应原接触后,可激发IgE介导的变应性炎性反应,整个过程有速发相反应阶段(可在数分钟内出现急性变应性症状)和迟发相反应阶段(接触变应原后6-9小时内达高峰,后逐渐消退,在此期间鼻腔粘膜中浸润的炎性细胞可再次激发速发相反应,使症状反复出现),这也是过敏性鼻炎易快速和反复发作的原因。
目前,过敏性鼻炎的治疗以鼻用皮质类固醇和抗组胺药物占核心地位,是临床一线治疗药物。鼻用皮质类固醇激素包括糠酸莫米松、丙酸氟替卡松、曲安奈德等。皮质类固醇对参与炎性反应的多种细胞的功能产生直接的抑制作用,可有效地减少鼻粘膜中抗原呈递细胞、肥大细胞、嗜碱性粒细胞和嗜酸性粒细胞等数量。但在缓解鼻部症状(特别是鼻塞)的同时也有一些缺陷,而且长期应用在药物不良反应方面医患仍有顾虑。抗组胺药:包括盐酸西替利嗪、氯雷他定等。抗组胺药物H1受体拮抗剂通过竞争性与H1受体结合而阻断组胺与H1受体的结合,从而抑制组胺发挥其生物学效应,达到控制过敏性鼻炎症状的目的,但对控制持续抗原暴露导致的迁延症状较差。白三烯受体拮抗剂:如:孟鲁司特钠。白三烯在变应性炎性反应速发相和迟发相中均起重要作用,抗白三烯治疗的作用机制可能是通过抑制产生组胺的炎性细胞(肥大细胞和嗜碱粒细胞)的产生、活化以及浸润而发挥药物作用。
中医药在治疗过敏性鼻炎方面积累了丰富的临床实践经验,中医药的成功介入和低廉的成本都显示了中医药在防治过敏性鼻炎领域具有优势。
中国历代医家对鼻鼽病因病机均有论述,概括起来主要是寒、热及体虚等所致。整体上看,其病机主要是体虚基础上外感风寒或风热犯肺,导致肺气失宣,鼻为肺之窍,以致鼻窍不畅。虚实夹杂,病情反复。鼻鼽病机衍化的基础是风热犯肺,在治疗上首先应审证求因,辨清寒热,从鼻涕的清浊、鼻黏膜的颜色、鼻涕量的多少、舌苔的厚薄、舌质的颜色、指纹的红紫来综合判断(若鼻黏膜苍白,鼻涕色清,质稀,舌淡、苔白,指纹红,属寒;若鼻黏膜红肿,流浊涕,质黏稠,舌红、苔黄厚腻,指纹紫,属热),在鼻鼽急性期以治标为主,对于痰未成而感受风寒所发者,以疏风解表、宣肺散寒为法;风热犯肺者,则以疏风解表、宣肺清热为法。 在痰已成阶段则应根据痰的寒热性质辨证选方,寒痰者以温肺化痰、宣通鼻窍为法;热痰者以清热化痰、宣通鼻窍为法。 在鼻鼽缓解期则以扶正为主,从肺、脾、肾三脏着手进行治疗,做到处方用药“因人制宜”。缓解期患儿久病不愈,气虚卫外不固、脾虚难以生金,阴虚肺失润养,故应益气养阴、扶正消风以治本,方选玉屏风散或沙参麦冬汤加减。
中医学对过敏性鼻炎的认识:
鼻为肺之官窍,仰赖肺气及宗气的宣布濡养。小儿肺常不足,卫表不固,易于感受外邪;鼻为肺之外窍,外邪侵袭,鼻部首当其冲,而六淫之邪中又以风邪致病为主,“风为百病之长”,鼻鼽临床或见偏寒偏热之不同,但总不离风邪为患。肺气虚则鼻塞不利,少气,实则喘喝,胸盈仰息。鼻窍的通畅依赖于脾胃的运化。若脾胃健运,水谷精微则可经脾气升清上输,润泽鼻窍,反之则易发为鼻鼽。肾为一身阴阳之本,肾气充足、肾阳充盛,则鼻窍通利、嗅觉聪敏、呼吸顺畅。
由以上论述可知,风热犯肺兼脾气虚弱型过敏性鼻炎的主要病机是本虚标实,本虚以脾气虚为主,标实以风热犯肺为主,脾气虚导致气血不足、肺气亦虚、气虚卫表不固,易感风热、风热易犯肺,故治疗应以疏风清肺、宣通鼻窍、益气健脾为主。
中医药在治疗过敏性鼻炎方面积累了比较丰富的临床实践经验,中医药的成功介入和低廉的成本都显示了中医药在防治过敏性鼻炎领域具有明显的优势。
经检索《新编国家中成药》中以鼻炎为主要治疗目的的中成药,目前比较多见,而内服剂型的品种数量较多,现列举代表成品如下:
(1)通窍鼻炎片 Z22021280
组成:由白术、白芷、薄荷、苍耳子、防风、黄芪、辛夷等组成;
功效:散风固表、宣肺通窍。用于肺气虚复感风邪型急性鼻炎、慢性鼻炎、过敏性鼻炎、鼻窦炎等鼻病。
(2)通窍鼻炎颗粒Z10980073
组成:由白术、白芷、薄荷、苍耳子、防风、黄芪、辛夷等组成
功效:散风消炎、宣通鼻窍。用于鼻渊、鼻塞、流涕、前额头痛;鼻炎、鼻窦炎及过敏性鼻炎。
(3)鼻炎康片 Z20023063
组成:广藿香、苍耳子、鹅不食草、麻黄、野菊花、当归、黄芩、猪胆粉、薄荷油、马来酸氯苯那敏。
功效:清热解毒、宣肺通窍、消肿止痛。用于风邪蕴肺所致的急、慢性鼻炎,过敏性鼻炎。
(4)辛芩颗粒 Z10950088
组成:由黄芪、白术、防风、细辛、荆芥、桂枝、白芷、石菖蒲、苍耳子、黄芩等组成。
功效:益气固表,祛风通窍。用于肺气不足、风邪外袭所致的鼻痒、喷嚏、流清涕、易感冒;过敏性鼻炎见上述证候者。
(5)鼻渊通窍颗粒 Z20030071
组成:由辛夷、炒苍耳子、麻黄、白芷、薄荷、藁本、黄芩、连翘、野菊花、天花粉、地黄、丹参、茯苓、甘草等组成。
功效:疏风清热,宣肺通窍。用于急鼻渊(急性鼻窦炎)属外邪犯肺证,证见:前额或颧骨部压痛,鼻塞时作,流涕粘白或粘黄,或头痛,或发热,苔薄黄或白,脉浮。
(6)辛夷鼻炎丸 Z44020046
组成:由辛夷、薄荷、紫苏叶、甘草、广藿香、苍耳子、鹅不食草、板蓝根、山白芷、防风、鱼腥草、菊花等组成。
功效:祛风、清热、解毒。主要用于治疗鼻炎。
中国专利公开号CN104398711A公开了一种用于治疗儿童过敏性鼻炎的中药组合物,它所含的活性成分由下列重量份原料药配比制备而成:蜜炙麻黄2~4份、桂枝2~4份、辛夷3~9份、苍耳子3~9份、五味子3~9份、乌梅3~9份、胆南星3~9份、徐长卿5~15份。还公开了上述药物的制备方法和应用。该中药组合物具有宣肺利窍,消风化痰之功效,临床研究证实对治疗儿童过敏性鼻炎具有显著疗效,不但可以改善过敏性鼻炎患儿的症状,而且可以在一定程度上改善患儿的特应性体质,是治疗儿童过敏性鼻炎的理想药物。
分析上述品种处方用药可知,多数是适用于成人的、以宣肺通窍、缓解鼻部症状为主的对症治疗,而目前市场上药理作用明确的、治疗儿童鼻炎的中成药非常少见,治疗上以宣通鼻窍、益气健脾为主的标本兼治的中成药更少见。
发明内容
本发明目的在于,提供一种用于治疗过敏性鼻炎的口服组合物,尤其适用于儿童。
本发明提供一种用于治疗过敏性鼻炎的口服组合物,按质量份计,包括:
2~3份辛夷、2~3份白芷、3~5份连翘、3~5份炒牛蒡子、2~3份防风、3~5份蒲公英、3~5份黄芪、3~5份黄芩、3~5份茯苓、3~5份白术、10~15份薏苡仁、2~3份川芎、2~3份玄参、1~2份甘草。
本发明组合物可以按传统中药制剂的制备方法制备得到。
本中药口服组合物具有疏风清肺、宣通鼻窍、益气健脾的功效。用于风热犯肺兼脾气虚弱型过敏性鼻炎,症见鼻塞、流涕、鼻痒、喷嚏,伴有纳呆、面白、多汗、易感冒,舌红,苔白,脉细;下鼻甲肥大、鼻腔黏膜水肿。
本发明的处方机理:
目前,过敏性鼻炎的治疗以对症治疗、缓解症状为主,同时尽量避免接触过敏源、注意休息、避免受凉、保持室内空气流通,避免继发性细菌感染等。缓解症状可使用药物治疗。
本证由风热犯肺兼脾气虚弱所致,治疗方法以疏风清肺、宣通鼻窍、益气健脾为主。方以辛夷、黄芩为君药。辛夷味辛性温,辛能外透肌热、疏散风邪,温能解肌散表,是治疗鼻病的要药。黄芩味苦性寒,具有清热燥湿、泻火解毒之功,又可助辛夷外透郁热。白芷、防风、川芎、黄芪、茯苓为臣药。其中,白芷散风解表、宣通鼻窍;防风祛风解表;川芎行气活血,祛风止痛;黄芪益气升阳,益气固表、利水消肿;茯苓健脾利水渗湿,五者助君药行疏散风邪、益气健脾之效。连翘清热解毒,疏散风热;炒牛蒡子疏散风热、宣肺利咽;蒲公英清热解毒、消痈散结;玄参清热凉血、滋阴降火、解毒散结;薏苡仁利湿健脾、舒筋除痹、清热排脓;白术固表止汗、补气健脾、燥湿利水,以上共为佐药。甘草清热解毒、润肺止咳,引药入肺为使药。诸药合用,共奏疏风清肺、宣通鼻窍、益气健脾之功效。其中,
辛夷 :辛、温。归肺、胃经。功能疏散风邪,通鼻窍。用于风邪外感、鼻塞流涕。本品味辛、温,尤善于疏散风邪,通鼻窍,是治疗鼻炎的要药。《本草新编》:“辛夷,通窍而上走于脑舍,(治)鼻塞鼻渊之症,无他用,存之以备用可耳。且辛散之物多用,则真气有伤,可暂用而不可久用也。”多配苍耳子、白芷等同用,如苍耳子散。现代药理研究显示辛夷有收缩鼻黏膜血管、促进黏膜分泌物的吸收,减轻炎症的作用,还有抑菌、镇痛、降压、抗过敏作用。
黄芩:味苦、性寒。归肺、胆、脾、大肠、小肠经。具有清热燥湿,泻火解毒,止血,安胎之功效。主治湿温、暑湿,胸闷呕恶,湿热痞满,泻痢,黄疸,肺热咳嗽,高热烦渴,血热吐衄,痈肿疮毒,胎动不安。《本草纲目·卷十三》∶"治风热,湿热,头痛,奔豚热痛,火咳肺痿,喉腥,诸失血"。《滇南本草》︰"上行泻肺火,下行泻膀胱火,男子五淋,女子暴崩,调经清热,胎有火热不安,清胎热,除六经实火实热” 。现代药理研究显示黄芩具有抗炎抗变态反应、抗微生物作用:黄芩有较广的抗菌谱,在试管内对痢疾杆菌、白喉杆菌、绿脓杆菌、葡萄球菌、链球菌、肺炎双球菌以及脑膜炎球菌等均有抑制作用,煎剂作喉头喷雾,对脑膜炎带菌者亦有效,即使对青霉素等抗菌素已产生抗药性的金黄色葡萄球菌,对黄芩仍属敏感。还具有解热、降压、利尿、利胆、解痉的作用。
白芷:味辛,性温。归肺,脾,胃经。具有散风解表、通窍止痛、止痒之功效。用于头痛、牙痛、风湿痹痛,鼻渊,带下证,疮痈肿毒。《药性论》:“治心腹血刺痛,除风邪,主女人血崩及呕逆,明目、止泪出,疗妇人沥血、腰腹痛;能蚀脓”。《日华子本草》:“治目赤胬肉,及补胎漏滑落,破宿血,补新血,乳痈、发背、瘰疬、肠风、痔瘘,排脓,疮痍、疥癣,止痛生肌,去面皯疵瘢”。《滇南本草》:“祛皮肤游走之风,止胃冷腹痛寒痛,周身寒湿疼痛”。《纲目》:“治鼻渊、鼻衄、齿痛、眉棱骨痛,大肠风秘,小便出血,妇人血风眩晕,反胃吐食;解砒毒,蛇伤,刀箭金疮”。现代药理学研究发现白芷香豆素具有抗高血压、抗凝血、抗微生物、抗病毒、抗癌、抗氧化等多种药理活性,还有明显的解热和镇痛作用。
防风:味辛、甘,性微温。归膀胱、脾、肝经。具有祛风解表、止痛、胜湿之功效。《神农本草经》:"主大风,头眩痛,恶风,风邪,目盲无所见,风行周身,骨节疼痹,烦满"。《名医别录》︰"胁痛肋风,头面去来,四肢挛急,字乳金疮内痉"。《本草蒙笙》︰"尽治—身之痛,而为风药中之润剂也气。治风通用,散湿亦宜"。现代药理学研究发现防风具有1. 镇痛作用:防风中的有效成分可抑制痛觉神经的兴奋,减轻疼痛感。2. 抗炎作用:防风中的化学成分具有抑制炎症反应和细胞因子产生的作用,能有效缓解炎症症状。3. 抗菌作用:防风中的成分能抑制多种细菌的生长繁殖,对多种感染有辅助治疗作用。4. 解热作用:防风中的成分可通过调节中枢神经系统,降低体温。
黄芪:味甘,性微温;归脾、肺经。具有益气升阳,固表止汗,排脓生肌,利水消肿的功效。《日华子本草》︰"黄耆助气壮筋骨,长肉补血,破癌癖,治漓病,瘦整,肠风,血崩,带下...前后一切病,月候不匀,消渴,痰嗽"。《本草汇言》︰"黄耆,补肺健脾,实卫敛汗,驱风运毒之药也"。现代药理学研究发现黄芪总皂苷小剂量可加重心力衰竭,而中等剂量和大剂量则有抗心力衰竭作用,对心肌的收缩舒张均有增强作用,且不增加心肌的耗氧量。黄芪能显著增加血液中的白细胞总数,促进中性粒细胞及巨噬细胞的吞噬功能和杀菌能力。黄芪能明显增强细胞免疫,促进PHA、PWM(美洲商陆)引起的淋巴细胞转化。黄芪多糖能升高正常大鼠红细胞的比容,增加红细胞数。对血虚证模型大鼠或小鼠,黄芪和黄芪多糖均能升高红细胞比容或血红蛋白含量。黄芪还能防治因辐射而造成的小鼠外周血白细胞总数、骨髓有核细胞数的减少,可促进造血干细胞的分化和增殖。
茯苓:味甘淡,性平。心、脾、肺经。具有健脾利水渗湿的功效。治小便不利,水肿胀满,痰饮咳逆,呕哕,泄泻,遗精,淋浊,惊悸,健忘。《本经》:"主胸胁逆气,忧恚惊邪恐悸,心下结痛,寒热烦满,咳逆,口焦舌干,利小便"。《本草衍义》︰"茯苓、茯神,行水之功多,益心脾不可阚也"。《世补斋医书》:"茯苓—味,为治痰主药。痰之本,水也,茯苓可以行水。痰之动,湿也,茯苓又可行湿"。现代药理学研究发现茯苓具有:利尿、抗菌、对溃疡有预防效果,并能降低胃酸、降低血糖的作用。
川芎:辛,温。归肝、胆、心包经。具有行气活血,祛风止痛的功效。主治:安抚神经,正头风头痛,症瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。《本经》∶"主中风入脑,头痛,寒痹,筋挛缓急,金疮,妇人血闭无子"。《本草衍义》︰“此药今人所用最多,头面风不可阙也,然须以他药佐之"。现代药理学研究发现川芎具有收缩心肌、扩张血管、降血压、抗心肌缺血、抗脑缺血、抑制血小板聚集、抗血栓形成、镇静、镇痛作用;川芎嗪对白三烯C4及D4、组织胺、PGF1a等所致豚鼠离体气管条的收缩作用均有一定的抑制作用,对哮喘的发作有防治作用。
连翘:味苦,性微寒;归肺、心、胆经。具有清热解毒,疏散风热的功效。主治:治风热感冒,咽喉肿痛,热病心烦、口渴,斑疹,热淋,痈疽肿毒,瘰疬,丹毒。《医学衷中参西录·药物》︰“连翘,具升浮宣散之力,流通气血,治十二经血凝气聚,为疮家要药。能透肌解表,清热逐风,又为治风热要药。且性能托毒外出,又为发表疹瘾要药” 。现代药理学研究发现连翘具有抗菌、抗真菌、抗病毒作用。连翘煎剂在体外对金黄色葡萄球菌、链球菌、肺炎球菌以及痢疾、伤寒、副伤寒、白喉、大肠、变形、鼠疫,人型结核等杆菌均有抑制作用;连翘酚(即连翘苷)对金黄色葡萄球菌、志贺氏痢疾杆菌有较强的抑制作用。
炒牛蒡子:辛苦,凉,入肺经、胃经。具有疏散风热、宣肺利咽的功效,主治风热咳嗽,咽喉肿痛,斑疹不透,风疹作痒,痈肿疮毒。《名医另别录》:“主明目,补中,除风伤"。《本草经疏》︰“恶实,为散风除热解毒之毒药。辛能散结,苦能泄热,热结散则脏气清明,故明目而补中。风之所伤,卫气必壅,壅则发热,辛凉解散则表气和,风无所留矣。......故用以瘾疹、痘疹,尤获奇验"。现代药理学研究发现炒牛蒡子具有预防麻疹、猩红热的作用。对于皮疹痤疮有很好的预防治疗作用。可用于降低血压的治疗和痤疮、直肠癌、肺癌的防治。有保护肾脏、防止尿潴留、降低血糖、延缓衰老的作用。
蒲公英:味苦、甘,性寒。归肝、胃经。具有清热解毒、消痈散结、利尿通淋的功效,主治疔疮肿毒,乳痈,瘰疬,目赤,咽痛,肺痈,肠痈,湿热黄疸,热淋涩痛。《本草经疏》:“蒲公英味甘平,其性无毒。当是入肝入胃,解热凉血之要药。乳痈属肝经,妇人经行后,肝经主事,故主妇人乳痈肿乳毒,并宜生暖之良”。《本草正义》:“蒲公英,其性清凉,治一切疗疮、痈疡、红肿热毒诸证,可服可敷,颇有应验,而治乳痈乳疗,红肿坚块,尤为捷效。鲜者捣汁温服,干者煎服,一味亦可治之,而煎药方中必不可缺此” 。现代药理学研究发现蒲公英具有抗氧化、降血糖、降血脂、抗炎、抗菌的作用。
玄参:味甘、苦、咸,性微寒。归肺、胃、肾经。具有清热凉血、滋阴降火、解毒散结的功效。主治热病伤阴,舌绛烦渴,温毒发斑,津伤便秘,骨蒸劳嗽,目赤,咽痛,瘰疠,白喉,痈肿疮毒。《本经》︰“主腹中寒热积聚,女子产乳余疾,补肾气,令人目明"。《本草品汇精要·卷十》:“消咽喉之肿,泻无根之火"。《本草纲目·卷十二》︰“滋阴降火,解斑毒,利咽喉,通小便血滞"。现代药理学研究发现玄参具有抗菌、降压、强心的作用。
薏苡仁:味甘、淡,性凉。归脾、胃、肺经。具有利湿健脾、舒筋除痹、清热排脓的功效。主治水肿,脚气,小便不利,脾虚泄泻,湿痹拘挛,肺痈,肠痈;赘疣。《本经》∶“主筋急构挛,不可屈伸,风湿痹,下气"。《本草纲目·卷二十三》:"薏苡仁阳明药也,能健脾、益胃。虚则补其母,故肺痈肺瘗用之。筋骨之病,以治阳明为本,故拘挛筋急、风痹者用之。土能胜水除湿,故泄痢水肿用之"。现代药理学研究发现薏苡仁具有抗肿瘤、镇痛抗炎、调节糖脂代谢、增强免疫、降血压、抗氧化、抗衰老、美白等功效。
白术:味苦、甘,性温。归脾、胃经。具有固表止汗、补气健脾、燥湿利水的功效。主治脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。《名医别爆》∶“主大风在身面,风眩头痛,目泪出,消痰水,逐皮间风水结肿,除心下急满及霍乱吐下不止,利腰脐间血,益津液,暖胃消谷,嗜食"。现代药理学研究发现白术具有具有利尿、抗菌、抗衰老、抗肿瘤等作用,对神经系统、子宫平滑肌、肠胃运动也有一定作用,还具有调节免疫功能。
甘草:味甘,性平。归心、肺、脾、胃经。具有补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药的功效。《本经》︰“主五脏六腑寒热邪气,坚筋骨,长肌肉,倍力,金洁肿,解毒”。《图经本草》:“甘草能解白药毒,为众药之要。"现代药理学研究发现甘草具有抗炎、抗肿瘤、抗菌、抗病毒、抗氧化和免疫调节等作用,且对心脑血管疾病、糖尿病和肝病等具有良好的治疗作用。
本发明提供了所述的口服组合物在治疗过敏性鼻炎药物中的应用。
在长期临床应用表明:本发明口服组合物对患者饮食及排泄功能无毒副作用,具有一定的安全性。由于该药物属于纯中药制剂,且不含有糖类成分,糖尿病患者也可放心服用。本发明运用中医辨证论治,结合大量的临床经验,形成此方。
本发明是以继承传统中医药理论,将长期治疗经验付诸临床应用,而开发的一种具有疏风清肺、宣通鼻窍、益气健脾的功效的用于风热犯肺兼脾气虚弱型过敏性鼻炎的中药制剂,症见鼻塞、流涕、鼻痒、喷嚏,伴有纳呆、面白、多汗、易感冒;舌红,苔白,脉细;下鼻甲肥大、鼻腔黏膜水肿。减轻了患者的症状,提高广大患儿的生活质量。
具体实施方式
提供一种用于治疗过敏性鼻炎的口服组合物配方,包括:
辛夷6g 白芷6g 连翘10g 炒牛蒡子10g
防风6g 蒲公英10g 黄芪10g 黄芩10g
茯苓10g 白术10g 薏苡仁30g 川芎6g
玄参6g 甘草2g
采用上述处方制备的中药口服药物,可以制成如汤药、或颗粒、药丸等中成药。
君:黄芩、辛夷
臣:白芷、防风、黄芪、茯苓、川芎
佐:连翘、炒牛蒡子、蒲公英、玄参、薏苡仁、白术
使:甘草
1、组成药味的功效:
黄芩:清热燥湿、泻火解毒
辛夷:疏散风寒,通鼻窍
白芷:散风解表、通窍止痛、止痒
防风:祛风解表、止痛、胜湿
黄芪:益气升阳,固表止汗,排脓生肌,利水消肿
茯苓:健脾利水渗湿
川芎:行气活血,祛风止痛
连翘:清热解毒,疏散风热
炒牛蒡子:疏散风热、宣肺利咽
蒲公英:清热解毒、消痈散结
玄参:清热凉血、滋阴降火、解毒散结
薏苡仁:利湿健脾、舒筋除痹、清热排脓
白术:固表止汗、补气健脾、燥湿利水
甘草:清热解毒、润肺止咳
2、方解:疏风清肺、宣通鼻窍、益气健脾
3、适应症:过敏性鼻炎或呼吸道感染引起的鼻塞、流涕、鼻痒、喷嚏等鼻部症状。
本实施例中药口服组合物研制成颗粒剂型或饮片,携带便携,服用简单,如下表1,将每位中药制备成颗粒剂型或饮片:
临床疗效十分显著。多年来,临床应用广泛,疗效肯定,口碑肯定,值得推广,为临床治疗过敏性鼻炎打下坚实的基础。本发明运用中医辨证论治,结合现代药理研究与多年的临床经验,采用中医药疗法减轻患者症状,提高临床疗效等方面积累了丰富的经验。并在长期的临床实践过程中,不断的优化和调整,紧扣该类疾病的核心病理环节,形成了此方。此方在临床应用多年,患者普遍反映服用后效果好,无副作用,深受患者青睐。
所得成药具有疏风清肺、宣通鼻窍、益气健脾。治疗风热犯肺兼脾气虚弱型儿童过敏性鼻炎。本制剂不仅适用范围广,疗效好,并与疾病的病机紧密切合,增加了患者的可选择性,满足广大的临床患者的需求。此方在临床使用中疗效突出、安全可靠,成功案例较多。临床疗效: 参照《中药新药临床研究指导原则( 试行) 》制定疗效标准。治愈: 鼻痒、鼻塞、喷嚏及流涕等临床症状消失,双下鼻甲无水肿,颜色正常; 显效: 鼻痒、鼻塞、喷嚏及流涕等临床症状明显减轻,仍有鼻甲轻度水肿者; 好转: 鼻痒、鼻塞、喷嚏及流涕等临床症状有所好转,但时有发作,仍有下鼻甲水肿者; 无效: 鼻痒、鼻塞、喷嚏及流涕等临床症状无好转或加重者。
本发明对用于一般以2周为一个疗程,儿童患者用上述处方总有效率达95%以上,没有出现副作用。
2018年至2023年对142名患儿的处方及疗效见表2:
本发明制备的中医药对过敏性鼻炎具有良好疗效,选用相应中药进行预防和治疗,可以收到显著的效果。
Claims (4)
1.一种用于治疗过敏性鼻炎的口服组合物,以辛夷、黄芩为君药,白芷、防风、川芎、黄芪、茯苓为臣药,甘草为使,其他为佐药,按质量份计,包括下述组份:
2~3份辛夷、2~3份白芷、3~5份连翘、3~5份炒牛蒡子、2~3份防风、3~5份蒲公英、3~5份黄芪、3~5份黄芩、3~5份茯苓、3~5份白术、10~15份薏苡仁、2~3份川芎、2~3份玄参、1~2份甘草。
2.根据权利要求1所述的用于治疗过敏性鼻炎的口服组合物,其特征在于,由下述组份组成:
辛夷6g、白芷6g、连翘10g、炒牛蒡子10g、防风6g、蒲公英10g、黄芪10g、黄芩10g、茯苓10g、白术10g、薏苡仁30g、川芎6g、玄参6g、甘草2g。
3.一种根据权利要求1或2所述的用于治疗过敏性鼻炎的口服组合物的制备方法,其特征在于,先将各组份制备成颗粒或粉剂,然后,按配方制备成包括汤药、颗粒剂、粉剂或药丸。
4.一种根据权利要求1或2所述的口服组合物在治疗过敏性鼻炎药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410970710.0A CN119386123A (zh) | 2024-07-19 | 2024-07-19 | 一种用于治疗过敏性鼻炎的口服组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410970710.0A CN119386123A (zh) | 2024-07-19 | 2024-07-19 | 一种用于治疗过敏性鼻炎的口服组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN119386123A true CN119386123A (zh) | 2025-02-07 |
Family
ID=94415896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410970710.0A Pending CN119386123A (zh) | 2024-07-19 | 2024-07-19 | 一种用于治疗过敏性鼻炎的口服组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN119386123A (zh) |
-
2024
- 2024-07-19 CN CN202410970710.0A patent/CN119386123A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102198236B (zh) | 一种治疗急性鼻窦炎的中药组合物及其制备方法 | |
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN103520694B (zh) | 治疗慢性阻塞性肺病稳定期的中药组合物及其制备方法 | |
KR20240102982A (ko) | 두드러기, 습진, 알레르기/변태반응체질 치료를 위한 중약제제 | |
CN112717113B (zh) | 一种治疗过敏性鼻炎中药组合物及其膏方和应用 | |
CN104784346A (zh) | 一种治疗瘙痒症的中药洗剂制备方法 | |
CN106389881A (zh) | 一种活血散瘀膏 | |
CN112870286B (zh) | 治疗特应性皮炎的中药组合物、制备方法及其应用 | |
CN103611005B (zh) | 一种治疗慢性咽炎的药物及其制备方法 | |
CN104998158A (zh) | 一种治疗肝硬化的药物组合物及其应用 | |
CN119386123A (zh) | 一种用于治疗过敏性鼻炎的口服组合物 | |
CN105194165B (zh) | 一种用于泌尿系统感染的中药及制备方法 | |
CN104547384A (zh) | 一种治疗百草枯中毒的口服液及制备方法 | |
CN104887950A (zh) | 一种治疗乳痈的中药组合物 | |
CN104689240A (zh) | 一种治疗气滞血瘀型黄褐斑的药物及其制备方法 | |
CN104225569A (zh) | 一种治疗慢性肠炎的中药组合物 | |
CN105709176A (zh) | 一种治疗心血瘀阻型心悸的中药组合物及其制备方法 | |
CN106267086A (zh) | 一种治疗原发性青光眼的中药制剂 | |
CN118924868A (zh) | 一种治疗咳嗽的中药外敷组合物 | |
CN104887808A (zh) | 一种治疗牙周炎的中药制剂 | |
CN104721752B (zh) | 一种治疗真性红细胞增多症的中药制剂及其制备方法 | |
CN105663585A (zh) | 中药组合物在制备治疗老年性皮肤瘙痒症药物中的用途 | |
CN105343394A (zh) | 一种治疗高血压的中药组合物 | |
CN104825846A (zh) | 一种治疗面神经炎的中药组合物 | |
CN105169111A (zh) | 一种用于治疗慢性荨麻疹的中药组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |